Drug intelligence / Profile preview

peritoneal dialysis solution

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Small Molecules
Administration
Intperitoneal
01

Overview

Baxter Peritoneal Dialysate refers to a portfolio of sterile, non-pyrogenic solutions manufactured by Baxter International for use in peritoneal dialysis (PD). These solutions are designed to treat patients with end-stage renal disease (ESRD) by facilitating the removal of metabolic waste products and excess fluid through the peritoneal membrane. The solutions typically contain an osmotic agent—most commonly dextrose (glucose), though icodextrin or amino acids are also used—to create an osmotic gradient that draws fluid from the blood into the peritoneal cavity. Additionally, they contain essential electrolytes (sodium, chloride, calcium, magnesium) and a buffering agent (lactate or bicarbonate) to maintain acid-base balance. Key products in this line include Dianeal, the standard glucose-based solution; Physioneal, which features a more physiological pH; Extraneal, containing icodextrin for long-dwell ultrafiltration; and Nutrineal, an amino acid-based solution for nutritional support.

Brand names
DianealPhysionealExtranealNutrineal
Other names
Baxter Peritoneal DialysatePD solutiondialysate

Beyond the preview

Go deeper on peritoneal dialysis solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on peritoneal dialysis solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call